Literature DB >> 28270178

Blood components are essential to regulate microcirculatory blood flow.

Nicolas Morel1, Marie Moisan2.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28270178      PMCID: PMC5341198          DOI: 10.1186/s13054-017-1621-5

Source DB:  PubMed          Journal:  Crit Care        ISSN: 1364-8535            Impact factor:   9.097


× No keyword cloud information.
We read with interest the article by Jacob and colleagues [1] on the regulation of microcirculatory blood flow. In our opinion, the authors missed an important parameter, i.e., blood components and, particularly, red blood cells (RBC). This is regrettable since blood composition is the main parameter that we can influence by our therapies (fluid resuscitation, blood or albumin transfusion) in shocked patients. RBC may use different contradictory pathways to modulate microvascular flow by modifying nitric oxide (NO) bioavailability, which is responsible for precapillary dilatation and capillary perfusion. On the one hand, erythrocytes may reduce NO bioavailability through hemoglobin NO scavenging; on the other hand, enhancing hematocrit may increase viscosity and wall shear stress (WSS), a crucial agonist enabling endothelium NO release. Thus, in hypoxic conditions, RBC may sense tissue oxygen tension and release vasodilatory agents such as NO or ATP. In moderate hemodilution, blood viscosity is reduced, cardiac output increases, wall shear rate (WSR; blood velocity) increases and WSS is unchanged (WSS = WSR × viscosity). NO bioavailability increases because of reduced NO scavenging by erythrocytes, leading to systemic vasoplegia. In extreme hemodilution [2] (hematocrit at 11%), viscosity, WSR, and WSS drop. Functional capillary density (FCD), which reflects microcirculatory flow, decreases. In this model, enhancing blood viscosity with high viscosity-plasma expander increased FCD. In the same way, in a murine model of hemorrhagic shock, transfusion of fresh RBC without oxygen-carrying capacity restored blood viscosity, and enhanced FCD, microvascular flow, and systemic hemodynamics. Recently, Tanaka and colleagues [3] observed that RBC transfusion improved sublingual FCD in humans in hemorrhagic shock with active blood loss. We have known since 1999 from the results of a trial using modified human hemoglobin in traumatic hemorrhagic shock [4] that modifying blood properties could be harmful. Patients in this study had a better blood systolic pressure than control patients, but more of them died. Free hemoglobin scavenges NO, enhancing precapillary vasoconstriction and impairing capillary perfusion. We do not share the authors’ opinion that it is “better to choose hemorrhagic rather than septic shock for yourself”. Guidelines for traumatic hemorrhagic shock management [5] do not consider RBC transfusion for their microcirculatory properties and viscosity improvement, but only for their oxygen-delivering capacity, which is altered for many hours after transfusion, when blood is stored. Recommending a low hemoglobin trigger delays RBC transfusion when microcirculation flow is already impaired. Nicolas Morel and Marie Moisan have drawn attention to the special but confounding role played by RBC in modulating regional microcirculatory flow distribution. As they correctly point out, contributory effects include changes in blood viscosity and scavenging or provision of vasoactive metabolites. Such influences must be expected, especially in conjunction with transfusions of RBC in situations of treatment or prevention of shock [6]. Although the effect of blood transfusion on blood viscosity and flow resistance has fascinated physiologists and experimental clinicians for over 100 years, the action of RBC on blood flow distribution has not been resolved satisfactorily. This is, in part, due to the fact that microvascular flow resistance arises mainly from the leukocyte component of whole blood, and not from RBC-mediated changes in viscosity [7]. With respect to scavenging of endothelium-derived vasodilatory NO by the hemoglobin of RBC, such an effect may be countered by the recently described presence of an active type-3 NO synthase in RBC [8]. In addition, supplying oxygen to the tissue provokes the production of vasoconstrictors in vivo. This realization has disproved other hypotheses proposing oxygen-dependent destruction or removal of vasodilators by RBC [9]. These few examples of the problems still associated with understanding the mechanisms by which RBC may influence regional flow distribution illustrate the continued necessity of conducting well-planned clinical studies for the improvement of patient outcome in situations of shock. Although at first sight the approach to management of traumatic hemorrhagic shock seems more clear than that of septic states, Morel and Moisan have provided good reasons why this is not resolved.
  9 in total

1.  Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion.

Authors:  Amy G Tsai; Cesar Acero; Patricia R Nance; Pedro Cabrales; John A Frangos; Donald G Buerk; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-12-02       Impact factor: 4.733

2.  Effect of RBC Transfusion on Sublingual Microcirculation in Hemorrhagic Shock Patients: A Pilot Study.

Authors:  Sebastien Tanaka; Etienne Escudier; Sophie Hamada; Anatole Harrois; Pierre Etienne Leblanc; Eric Vicaut; Jacques Duranteau
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

Review 3.  Arteriolar oxygen reactivity: where is the sensor and what is the mechanism of action?

Authors:  William F Jackson
Journal:  J Physiol       Date:  2016-07-21       Impact factor: 5.182

4.  Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial.

Authors:  E P Sloan; M Koenigsberg; D Gens; M Cipolle; J Runge; M N Mallory; G Rodman
Journal:  JAMA       Date:  1999-11-17       Impact factor: 56.272

Review 5.  Red blood cell transfusion and its effect on microvascular dysfunction in shock states.

Authors:  Jordan A Weinberg; Rakesh P Patel
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2016-11-03

6.  The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition.

Authors:  Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn
Journal:  Crit Care       Date:  2016-04-12       Impact factor: 9.097

Review 7.  Endothelial nitric oxide synthase in red blood cells: key to a new erythrocrine function?

Authors:  Miriam M Cortese-Krott; Malte Kelm
Journal:  Redox Biol       Date:  2014-01-09       Impact factor: 11.799

Review 8.  Regulation of blood flow and volume exchange across the microcirculation.

Authors:  Matthias Jacob; Daniel Chappell; Bernhard F Becker
Journal:  Crit Care       Date:  2016-10-21       Impact factor: 9.097

9.  Microcirculatory effects of the transfusion of leukodepleted or non-leukodepleted red blood cells in patients with sepsis: a pilot study.

Authors:  Abele Donati; Elisa Damiani; Michele Luchetti; Roberta Domizi; Claudia Scorcella; Andrea Carsetti; Vincenzo Gabbanelli; Paola Carletti; Rosella Bencivenga; Hans Vink; Erica Adrario; Michael Piagnerelli; Armando Gabrielli; Paolo Pelaia; Can Ince
Journal:  Crit Care       Date:  2014-02-17       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.